Nanotics

NaNotics to Collaborate With Mayo Clinic on Nanomedicine Cancer Treatment

PRESS RELEASE — —NaNotics LLC, a nanomedical company focused on developing and commercializing NaNots™, a novel subtractive nanoparticle that treats disease by capturing and clearing pathogenic molecules from blood, announced a research collaboration with Mayo Clinic to develop a NaNot that targets the soluble form of PD-L1, a tumor-generated immune inhibitor. The goal is to …

NaNotics to Collaborate With Mayo Clinic on Nanomedicine Cancer Treatment Read More »